Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting

Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract disease in children worldwide and is a significant cause of hospital admissions in young children in England. No RSV vaccine has been licensed but a number are under development. In this work, we present two structurally d...

Detaylı Bibliyografya
Asıl Yazarlar:	Kinyanjui, T, Pan-Ngum, W, Saralamba, S, Taylor, S, White, L, Nokes, DJ
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2020

Benzer Materyaller

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
Yazar:: Timothy Kinyanjui, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
Yazar:: Pan-Ngum, W, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, Kenya
Yazar:: Nyiro, JU, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)
Yazar:: Mahikul, W, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
Yazar:: Wiriya Mahikul, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
Yazar:: Samuel PC Brand, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
Yazar:: Ralph A. Tripp, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
Yazar:: Leonard R. Krilov, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
Yazar:: Mohamad El Labban, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting.
Yazar:: Timothy M Kinyanjui, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
Yazar:: Xiao Li, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Yazar:: Asunci&oacute;n Mej&iacute;as, ve diğerleri
Baskı/Yayın Bilgisi: (2008-09-01)

Cost-Effectiveness Analysis of Maternal Respiratory Syncytial Virus Vaccine in Protecting Infants from RSV Infection in Japan
Yazar:: Naruhiko Ishiwada, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Airway gene-expression classifiers for respiratory syncytial virus (RSV) disease severity in infants
Yazar:: Lu Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
Yazar:: Drysdale, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
Yazar:: Jackelyn Murray, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
Yazar:: Dvir Gatt, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
Yazar:: Gengxin Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Implications of gestational age at antenatal care attendance on the successful implementation of a maternal respiratory syncytial virus (RSV) vaccine program in coastal Kenya
Yazar:: Nyiro, JU, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Characteristics of the First Italian Older Adults Vaccinated with an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine
Yazar:: Alexander Domnich, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
Yazar:: Shira Hirsh, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
Yazar:: Mark R. Ackermann, ve diğerleri
Baskı/Yayın Bilgisi: (2012-10-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
Yazar:: White, L, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Respiratory syncytial virus (RSV) in infants hospitalized for acute lower respiratory tract disease: incidence and associated risks
Yazar:: Adriana Gut Lopes Riccetto, ve diğerleri

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
Yazar:: Rachel J Derscheid, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya
Yazar:: Nyiro, JU, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
Yazar:: Patricia T. Campbell, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya
Yazar:: Joyce U. Nyiro, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
Yazar:: White, L, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Inpatient service utilization amongst infants diagnosed with Respiratory Syncytial Virus infection (RSV) in the United States.
Yazar:: Jason R Gantenberg, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types
Yazar:: Lydia J. Atherton, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
Yazar:: Alejandro Larios Mora, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
Yazar:: Selir M. Straliotto, ve diğerleri
Baskı/Yayın Bilgisi: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
Yazar:: Selir M. Straliotto, ve diğerleri
Baskı/Yayın Bilgisi: (1994-03-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
Yazar:: Antepowicz, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
Yazar:: Envera Lekic, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
Yazar:: Andrea Gastaldi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
Yazar:: Harrison C. Bergeron, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
Yazar:: Sameer Joshi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
Yazar:: Enders Martin, ve diğerleri
Baskı/Yayın Bilgisi: (2005-03-01)